Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
HK Stock MarketDetailed Quotes
02607 SH PHARMA
- 10.580
- -0.020-0.19%
Trading Apr 30 13:36 CST
39.23BMarket Cap8.34P/E (TTM)
10.700High10.560Low2.04MVolume10.640Open10.600Pre Close21.63MTurnover0.22%Turnover Ratio7.98P/E (Static)3.71BShares14.70052wk High0.50P/B9.72BFloat Cap9.95352wk Low0.53Dividend TTM919.07MShs Float24.612Historical High0.440Dividend LFY1.32%Amplitude2.037Historical Low10.605Avg Price100Lot Size4.98%Div YieldTTM4.16%Div Yield LFY
SH PHARMA Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.87%70.76B | 5.75%275.25B | 6.14%209.63B | 5.14%139.41B | 5.93%70.15B | 12.21%260.3B | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B |
| Operating income | 0.87%70.76B | 5.75%275.25B | 6.14%209.63B | 5.14%139.41B | 5.93%70.15B | 12.21%260.3B | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B |
| Operating expenses | -2.22%-63.51B | -6.84%-244.62B | -7.44%-186.45B | -6.67%-123.25B | -7.87%-62.12B | -13.63%-228.97B | -14.22%-173.55B | -19.50%-115.53B | -16.19%-57.59B | -7.59%-201.49B |
| Gross profit | -9.61%7.26B | -2.22%30.63B | -3.28%23.18B | -5.22%16.17B | -7.03%8.03B | 2.76%31.33B | 5.67%23.96B | 13.51%17.06B | 17.80%8.63B | 6.81%30.49B |
| Selling expenses | 16.11%-2.76B | 8.55%-12.71B | 9.46%-9.48B | 15.10%-6.57B | 15.86%-3.29B | 2.64%-13.9B | -1.29%-10.47B | -13.81%-7.73B | -18.05%-3.91B | -7.22%-14.28B |
| Administrative expenses | 4.81%-1.32B | 0.38%-5.69B | 1.22%-4.14B | -3.86%-2.87B | -0.90%-1.39B | -14.43%-5.71B | -11.62%-4.19B | -19.00%-2.76B | -15.70%-1.38B | 2.95%-4.99B |
| Research and development expenses | 0.88%-497.02M | -8.64%-2.39B | -10.09%-1.62B | -7.67%-1.11B | 7.26%-501.45M | -4.35%-2.2B | -5.70%-1.47B | -26.76%-1.03B | -20.82%-540.69M | -6.29%-2.11B |
| Profit from asset sales | -100.82%-903.05K | 103.26%187.97M | 39.44%145.83M | 88.91%139.31M | 405.21%110.04M | -93.57%92.48M | -92.67%104.58M | -94.83%73.75M | 188.72%21.78M | 2,368.58%1.44B |
| Revaluation surplus | -27.65%37.8M | -49.63%203.85M | -40.51%142.2M | -41.94%114.29M | -41.55%52.25M | 85.03%404.73M | 225.04%239.02M | 675.23%196.84M | 240.65%89.4M | 206.18%218.74M |
| -Changes in the fair value of other assets | -27.65%37.8M | -49.63%203.85M | -40.51%142.2M | -41.94%114.29M | -41.55%52.25M | 85.03%404.73M | 225.04%239.02M | 675.23%196.84M | 240.65%89.4M | 206.18%218.74M |
| Impairment and provision | 8.25%-221.85M | 0.08%-840.54M | -89.25%-496.97M | -22.04%-329.78M | -42.34%-241.8M | -30.64%-841.24M | -15.91%-262.6M | -51.60%-270.22M | -362.28%-169.87M | -360.73%-643.93M |
| -Other impairment is provision | 8.25%-221.85M | 0.08%-840.54M | -89.25%-496.97M | -22.04%-329.78M | -42.34%-241.8M | -30.64%-841.24M | -15.91%-262.6M | -51.60%-270.22M | -362.28%-169.87M | -360.73%-643.93M |
| Special items of operating profit | 0.94%235.46M | 39.96%1.01B | 96.95%682.34M | 124.15%384.1M | -34.56%233.27M | -21.78%725.04M | -49.72%346.45M | -61.50%171.36M | 41.47%356.49M | -59.88%926.88M |
| Operating profit | -9.61%2.52B | 5.12%9.62B | 1.40%7.82B | 3.86%5.54B | -4.11%2.79B | -11.38%9.15B | -10.54%7.71B | -17.32%5.33B | 23.59%2.91B | 9.28%10.33B |
| Financing cost | -0.08%-374.72M | 0.33%-1.48B | 0.45%-1.15B | 8.70%-705.94M | 10.46%-374.43M | -13.14%-1.49B | -15.71%-1.15B | -19.16%-773.22M | -16.64%-418.18M | -5.45%-1.31B |
| Adjustment items of earning before tax | 213.51%6.33M | 80.31%-120.71M | 34.01%-24.39M | 63.46%-8.88M | 54.93%2.02M | -197.11%-612.94M | 30.84%-36.96M | 41.10%-24.29M | 115.24%1.3M | -234.51%-206.3M |
| Earning before tax | -10.92%2.15B | 13.69%8.02B | 1.92%6.64B | 6.36%4.82B | -3.02%2.42B | -19.91%7.05B | -13.86%6.52B | -21.26%4.53B | 25.44%2.49B | 8.16%8.81B |
| Tax | 7.00%-512.52M | -13.89%-2.15B | -3.57%-1.62B | -9.66%-1.22B | -2.28%-551.13M | -3.93%-1.89B | 1.16%-1.57B | 6.45%-1.12B | -18.63%-538.85M | 2.83%-1.82B |
| After-tax profit from continuing operations | -12.08%1.64B | 13.62%5.87B | 1.40%5.02B | 5.28%3.6B | -4.48%1.87B | -26.11%5.17B | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B |
| Earning after tax | -12.08%1.64B | 13.62%5.87B | 1.40%5.02B | 5.28%3.6B | -4.48%1.87B | -26.11%5.17B | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B |
| Minority profit | -5.00%307.12M | -5.80%1.32B | -16.24%969.12M | -18.80%655.45M | -25.75%323.29M | 1.72%1.4B | -1.14%1.16B | -7.07%807.18M | 54.77%435.4M | 16.41%1.37B |
| Profit attributable to shareholders | -13.56%1.33B | 20.82%4.55B | 6.78%4.05B | 12.72%2.94B | 1.62%1.54B | -32.92%3.77B | -21.13%3.8B | -29.38%2.61B | 21.31%1.52B | 10.28%5.62B |
| Basic earnings per share | -14.29%0.36 | 20.59%1.23 | 5.83%1.09 | 11.27%0.79 | 2.44%0.42 | -36.65%1.02 | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 |
| Diluted earnings per share | -14.29%0.36 | 20.59%1.23 | 5.83%1.09 | 11.27%0.79 | 2.44%0.42 | -36.65%1.02 | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts